BERJENY Trademark

Trademark Overview


On Monday, July 28, 2014, a trademark application was filed for BERJENY with the United States Patent and Trademark Office. The USPTO has given the BERJENY trademark a serial number of 86349873. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 14, 2017. This trademark is owned by Glaxo Group Limited. The BERJENY trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e))Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metab...
berjeny

General Information


Serial Number86349873
Word MarkBERJENY
Filing DateMonday, July 28, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 14, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2015

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e))Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 5, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, August 14, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 14, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 17, 2016EXTENSION 3 GRANTED
Tuesday, December 6, 2016EXTENSION 3 FILED
Tuesday, December 6, 2016TEAS EXTENSION RECEIVED
Thursday, August 4, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 3, 2016EXTENSION 2 GRANTED
Wednesday, June 29, 2016EXTENSION 2 FILED
Friday, July 29, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 29, 2016TEAS EXTENSION RECEIVED
Wednesday, December 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 21, 2015EXTENSION 1 GRANTED
Monday, December 21, 2015EXTENSION 1 FILED
Monday, December 21, 2015TEAS EXTENSION RECEIVED
Tuesday, July 14, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 19, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 10, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 9, 2015DATA MODIFICATION COMPLETED
Wednesday, April 8, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 8, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 2, 2015ASSIGNED TO LIE
Friday, March 27, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 10, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 10, 2014LETTER OF SUSPENSION E-MAILED
Monday, November 10, 2014SUSPENSION LETTER WRITTEN
Monday, November 10, 2014ASSIGNED TO EXAMINER
Tuesday, August 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 31, 2014NEW APPLICATION ENTERED IN TRAM